Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity

Laryngoscope

Volumn 123, Issue 8, 2013, Pages 1903-1911

  Yu, Fenggang ^a   Sim, Adrian Chong Nyi ^a   Li, Chunwei ^a   Li, Yingying ^a   Zhao, Xuening ^b   Wang, De Yun ^a   Loh, Kwok Seng ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

aldehyde dehydrogenase; C666 1 cell line; cancer stem like cells; Epstein Barr virus associated; Nasopharyngeal carcinoma; therapy resistant

Indexed keywords

ALDEHYDE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CELL POPULATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL STUDY; FEMALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDEHYDE DEHYDROGENASE; C666-1 CELL LINE; CANCER STEM-LIKE CELLS; EPSTEIN-BARR VIRUS ASSOCIATED; NASOPHARYNGEAL CARCINOMA; THERAPY RESISTANT;

ALDEHYDE DEHYDROGENASE; ANIMALS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL SEPARATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NASOPHARYNGEAL NEOPLASMS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84880566464     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24003     Document Type: Article

References (33)

1. Chen CJ, Liang KY, Chang YS, et al. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 1990; 10: 547-553.
2. Pardal R, Clarke MF, Morrison SJ,. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003; 3: 895-902.
3. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648.
4. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
5. O'Brien CA, Pollett A, Gallinger S, Dick JE,. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2006; 445: 106-110.
6. Prince M, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci 2007; 104: 973-978.
7. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344.
8. Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci 1999; 96: 9118-9123.
9. Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005; 23: 752-760.
10. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
11. Su J, Xu XH, Huang Q, et al. Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line. Arch Med Res 2011; 42: 15-21.
12. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH,. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007; 67: 3716-3724.
13. Cheung ST, Huang DP, Hui ABY, et al. Nasopharyngeal carcinoma cell line (C666-1-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999; 83: 121-126.
14. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5823.
15. Clay MR, Tabor M, Owen JH, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-1201.
16. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-338.
17. Li T, Su Y, Mei Y, et al. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2009; 90: 234-244.
18. Yoshioka T, Umekita Y, Ohi Y, et al. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study. Histopathology 2011; 58: 608-616.
19. Landen CN Jr, Goodman B, Katre AA, et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 2010; 9: 3186-3199.
20. + human breast cancer cells. Breast Cancer Res Treat 2012; 133: 75-87.
21. Doherty R, Haywood Small S, Sisley K, Cross N,. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells. Biochem Biophys Res Commun 2011; 414: 801-807.
22. Yu C, Yao Z, Dai J, et al. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines. In Vivo 2011; 25: 69-76.
23. Chaffer CL, Brueckmann I, Scheel C, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci 2011; 108: 7950-7955.
24. Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009; 15: 4234-4241.
25. + cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6: 603-615.
26. Li XP, Li C, Li X, et al. Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol Cancer Ther 2006; 5: 1290-1298.
27. Cao JX, Cui YX, Long ZJ, et al. Pluripotency-associated genes in human nasopharyngeal carcinoma CNE-2 cells are reactivated by a unique epigenetic sub-microenvironment. BMC Cancer 2010; 10: 68.
28. Marcato P, Dean CA, Pan D, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011; 29: 32-45.
29. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RCM, van der Pluijm G,. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis 2011; 28: 615-625.
30. Herrera-Gayol A, Jothy S,. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp Mol Pathol 1999; 66: 99-108.
31. Kondo S, Wakisaka N, Muramatsu M, et al. Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol 2011; 85: 11255-11264.
32. Kong QL, Hu LJ, Cao JY, et al. Epstein-Barr virus-encoded LMP2A Induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 2010; 6: e1000940.
33. Luo WR, Qian GF, Li SY, Yao KT,. Tumour budding and the expression of cancer stem cell marker ALDH1 in nasopharyngeal carcinoma. Histopathology 2012; 61: 1072-1081.